News
CDT Equity
CDT · NASDAQ
$0.159−$0.027 (−14.52%)TodayMarket closed ·
Prev close $0.186
Latest news
- NewsAvi Kapoor
Nasdaq Dips Over 400 Points; Bank of America Shares Tumble After Q3 Results
- NewsAvi Kapoor
Dow Gains Over 100 Points; US Inflation Rate Rises In September
- Press releaseGlobe Newswire
CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset
- Press releaseGlobe Newswire
CDT Highlights Sarborg’s Expanding Quantum Computing IP Portfolio and Application to Drug Discovery
- NewsAvi Kapoor
Dow Jumps Over 1%; US Inflation Holds at 3.4% In August
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Nasdaq Down Over 200 Points; US Producer Inflation Rises to 5.4% In August
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
CDT Highlights Sarborg’s Application of Signature Intelligence and Quantum Computing Models to Mental Health
- NewsAvi Kapoor
Crude Oil Moves Higher; US Factory Orders Rise In July
- NewsAvi Kapoor
Dow Surges Over 200 Points; Ollie's Bargain Outlet Shares Gain After Q2 Earnings
- NewsAvi Kapoor
Why Dell Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
- NewsTanya Rawat
CDT Equity (CDT) Shares Fall 21% After Hours: Here's What Happened
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsAvi Kapoor
Why Cadeler Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releaseGlobe Newswire
CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsKaustubh Bagalkote
Why Is CDT Equity Stock Surging On Monday?
- NewsEvette Mitkov
CDT Equity Stock Gets A Boost On SarborgQ Development News
- NewsAvi Kapoor
Crude Oil Down 2%; Accenture Shares Fall After Q3 Results
- NewsAvi Kapoor
Nasdaq Surges 300 Points; US Initial Jobless Claims Edge Lower
- Press releaseGlobe Newswire
CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseGlobe Newswire
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseGlobe Newswire
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- NewsAvi Kapoor
Why Heartbeam Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket
- News
CDT Equity Announces Strategic Purchase Of ~8.65 Bitcoin For $1M At An Average Price Of $115,285 Per BTC
- Press releaseGlobe Newswire
CDT Executes Cryptocurrency Treasury Reserve Strategy
- Press releaseGlobe Newswire
Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy
- Press releaseGlobe Newswire
Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseGlobe Newswire
Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health
- Press releaseGlobe Newswire
Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.